GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.85
Bid: 50.10
Ask: 50.30
Change: -2.35 (-4.50%)
Spread: 0.20 (0.399%)
Open: 53.40
High: 53.40
Low: 49.85
Prev. Close: 52.20
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio co Ceres finalises deal with Weichai

4 Dec 2018 17:49

RNS Number : 4464J
IP Group PLC
04 December 2018
 

FOR RELEASE ON

04 December 2018

 

IP Group plc - Portfolio company Ceres Power finalises strategic collaboration with Weichai; further £28m investment

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, is pleased to note that portfolio company Ceres Power Holdings plc ("Ceres", "Ceres Power" or "the Company") and Weichai Power ("Weichai"), one of the leading automobile and equipment manufacturing companies in China, have agreed a long-term strategic collaboration.

 

The agreement, which triggers a further £28m equity injection into Ceres Power, includes a Joint Venture Agreement with the commitment to create a fuel cell manufacturing JV in China, a License Agreement to transfer key technology to the JV and a new £9 million joint development agreement.

 

Prior to the new equity investment by Weichai, IP Group currently holds a direct undiluted beneficial stake of 21.3% in Ceres, developer of the SteelCell®, a world-leading, low cost Solid Oxide Fuel Cell technology.

 

Dr Robert Trezona, Head of Cleantech at IP Group, said: "Ceres Power continues to make excellent commercial progress, having signed agreements with Weichai and Bosch this year. The Company is also well funded having completed a significantly oversubscribed £20m fundraising in July as well as having agreed a combined £57m of new investment from Weichai and Bosch. Since IP Group's investment in Ceres in 2012, the Company has gone from strength to strength and is a great example of how we've helped to create a world-leading company based on scientific research carried out in the UK."

 

The highlights of Ceres' announcement are:

 

- A new Joint Development Agreement (JDA) worth £9m to Ceres for the continued development of a first range extender product for electric buses in China.

- A Joint Venture Agreement for Ceres and Weichai to invest in a major new fuel cell manufacturing facility in Shandong, China, following successful trials.

- A License Agreement which will result in significant staged Technology Transfer payments of up to £30m, and ongoing future royalties to Ceres.

- Weichai will invest a further £28m in Ceres through the exercise of its warrant at 164.5p per share to increase its stake in Ceres from just under 10% to 20%. This brings its total equity investment in Ceres to £48m.

 

Ceres has completed a number of collaborations this year including a strategic collaboration with Robert Bosch GmbH as well as a £9m strategic equity investment by Bosch into Ceres in August. Prior to that, Ceres signed a new partnership with Nissan to further develop fuel cell technology for EV applications which saw Ceres and The Welding Institute awarded a total of £8m UK Government funding through the Advanced Propulsion Centre for the project.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive OfficerGreg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

Andrew Wilson

+44 (0) 7810 636995

Martha Walsh

+44 (0) 7876 245962

Tom Gillingham

+44 (0) 7741 659021

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUGGQCPUPRGMC
Date   Source Headline
16th May 20187:00 amRNSNotice of AGM; Annual Report
11th May 20187:00 amRNSDirector/PDMR Shareholding
10th May 20186:18 pmRNSDirector/PDMR Shareholding
9th May 20185:31 pmRNSDirector share purchase
4th May 20187:00 amRNSBoard changes
30th Apr 20187:00 amRNSTotal Voting Rights
16th Apr 20185:45 pmRNSDirector/PDMR Shareholding
12th Apr 20189:19 amRNSEnterprise Therapeutics raises £29m
5th Apr 20181:12 pmRNSIP Group plc - Issue of Equity
4th Apr 201811:46 amRNSIP Group plc - Director/PDMR share purchase
29th Mar 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSOxford Nanopore announces £100m fundraising
17th Jan 201811:53 amRNSHolding(s) in Company
10th Jan 20189:12 amRNSHolding(s) in Company
2nd Jan 20187:00 amRNSTotal Voting Rights
18th Dec 201710:15 amRNSAutifony signs Eur627.5m agreement with BI
15th Dec 201712:50 pmRNSDiurnal receives positive CHMP opinion for Alkindi
14th Dec 20174:48 pmRNSDirectorate Change
13th Dec 20172:27 pmRNSIssue of Equity
8th Dec 20177:05 amRNSMirriad raises £26.2m; proposed admission to AIM
6th Dec 20172:32 pmRNSIssue of Equity
30th Nov 201712:40 pmRNSTotal Voting Rights
27th Nov 20176:27 pmRNSIssue of Equity
22nd Nov 20175:50 pmRNSHolding(s) in Company
22nd Nov 20173:23 pmRNSIssue of Equity
15th Nov 201712:47 pmRNSIssue of Equity
14th Nov 201712:29 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSNotice of cancellation of admission to AIM
9th Nov 201711:11 amRNSIssue of Equity
8th Nov 20175:11 pmRNSHolding(s) in Company
6th Nov 20173:50 pmRNSIssue of Equity
6th Nov 20177:00 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSHolding(s) in Company
31st Oct 20175:35 pmRNSHolding(s) in Company
31st Oct 20175:20 pmRNSTotal Voting Rights
26th Oct 20173:50 pmRNSIssue of Equity
19th Oct 20173:20 pmRNSForm 8.3 - IP Group PLC
19th Oct 201710:38 amRNSForm 8.5 (EPT/RI) - IP Group Plc
18th Oct 20175:02 pmRNSForm 8.5 (EPT/RI) - IP Group Plc Amendment
18th Oct 20173:20 pmRNSForm 8.3 - IP Group PLC
18th Oct 201710:33 amRNSForm 8.5 (EPT/RI) - IP Group Plc
18th Oct 201710:30 amRNSOffer Update; Appointment of Prof. David Begg
18th Oct 20177:00 amRNSOffer Update - Wholly Unconditional
17th Oct 20174:05 pmRNSForm 8.3 - IP Group Plc
17th Oct 20173:20 pmRNSForm 8.3 - IP Group plc
17th Oct 201710:27 amRNSForm 8.5 (EPT/RI) - IP Group Plc
17th Oct 20177:36 amRNSOffer Update - CMA clearance and Offer timetable
16th Oct 20173:20 pmRNSForm 8.3 - IP Group PLC
16th Oct 20172:41 pmRNSForm 8.3 - IP Group Plc
16th Oct 201710:57 amRNSForm 8.5 (EPT/RI) - IP Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.